Lost in Translation
Thursday, October 4, 2012
Missing Reports: Research Biopsy in Cancer Trials
›
A growing number of drug trials are collecting tissue to determine whether the drug hits its molecular target. These studies...
1 comment:
Monday, August 20, 2012
Targeted Cancer Drugs: The "Price of Progress"?
›
S o here is the party line on the newest generation of cancer drugs. Unlike older generation drugs, which are generalized poisons, newer...
3 comments:
Wednesday, May 2, 2012
Registration of Trials: A Census
›
Apologies to the millions of avid followers of Lost in Translation for the long haitus. In response to an international petition campaign...
Monday, March 21, 2011
Tea Leaves: Predicting Risk and Benefit in Translation
›
E very early phase trial begins with a series of predictions: that a new drug will show clinical utility down to road, that risks to study v...
2 comments:
Tuesday, February 8, 2011
Dirty Windows of Drug Development
›
T hink of clinical trial data as a window on the efficacy and safety of a drug. Think of data protection and trade secrecy as soot. The abov...
1 comment:
Monday, December 20, 2010
More Gray Matter: Parkinson's Disease and Gene Transfer
›
S everal groups are pursuing gene transfer strategies against Parkinson's disease. No small task, because for these approaches to work, ...
Monday, November 29, 2010
Icarus, again: Adversity in another Gene Transfer Trial
›
Two weeks ago brought good news and bad news for gene transfer. First the good news. New England Journal of Medicine beatified a new ge...
›
Home
View web version